Maryland grandfather sounds alarm on potential vision loss risk posed by weight-loss medication

1 week ago 17

Todd Engel, 63, was first prescribed Ozempic in 2023 to help manage his diabetes. Approximately four months later, he was diagnosed with NAION (nonarteritic anterior ischemic optic neuropathy).

*** Disclaimer: This Article is auto-aggregated by a Rss Api Program and has not been created or edited by Bdtype.

(Note: This is an unedited and auto-generated story from Syndicated News Rss Api. News.bdtype.com Staff may not have modified or edited the content body.

Please visit the Source Website that deserves the credit and responsibility for creating this content.)

Watch Live | Source Article